Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,613.40up ₹33.40 (0.73%)BSE ₹4,635.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹4,580.00.
30 Oct: open ₹4,560.00, high ₹4,672.00, low ₹4,532.00
52-week range of traded prices to 30 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,75,479 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.82%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,36,64564.6% delivered
Torrent Pharmaceuticals share news and announcements
865 announcements, routine notices left out, newest first. Page 17 of 18.
Aug 2010
Jul 2010
9 Jul · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2010.8 Jul · Dividend
Dividend on the Equity Share of the Company for the financial year 2009-10, if approved by the shareholders at the ensuing Annual General Meeting, shall be payable on August 03, 2010.6 Jul · Meeting
Annual General Meeting of the members of the Company will be held on July 30, 2010.
May 2010
18 May · Corporate action
Share Transfer Books and Registers of Members of the Company will remain close from June 08, 2010 to June 10, 2010 (both days inclusive) for the purpose of Dividend entitlement for the year 2009-10.6 May · Dividend
Board of Directors at its meeting held on May 06, 2010 has recommended a dividend of Rs. 6.00 per equity share having face value of Rs. 5/- each.
Apr 2010
20 Apr · Board meeting
To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2010 and recommendation of dividend for the financial year 2009-10.
Mar 2010
19 Mar · Disclosure
Intimation under Regulation 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (Insider Trading Code) with respect to change in shareholding due to change in shareholding due to inter se transfer of shares in the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Mar · Disclosure
Torrent Pharmaceuticals Ltd. has submitted to the Exchange a copy of intimation under Regulation 7(3) of SEBI (Substantial Acquisition and Takeover) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Mar · Disclosure
Torrent Pharmaceuticals Ltd. has informed the Exchange that the following intimations are received on March 18, 2010 from Sudhir Mehta and Samir Mehta, Directors, under Regulation 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Mar · Disclosure
Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 1997 (Takeover Code) with respect to inter se transfer of shares in 'Torrent Pharmaceuticals Ltd.' The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Disclosure
Regulation 3(3) of SEBI (Substantial Acquisition of Shares and Takeover Regulations, 1997 (Takeover Code) with respect to inter se transfer of shares in "Torrent Pharmaceuticals Ltd." The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
27 Jan · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Q3 PAT jump 64% at Rs. 83 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jan · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis as per clause 41 of the Listing Agreement for the quarter and nine months ended on December 31, 2009.
Dec 2009
4 Dec · Updates
Torrent Pharmaceuticals Ltd. has informed the Exchange that: "There are reports in certain sections of media about potential stake sell by the Company. The Company denies that it or its promoters intend to sell any stake to Takeda Pharmaceuticals Limited, Japan. There is no move on the part of the Company or its promoters to sell stake, in part or in whole, to any player, national or global. The Company had sent its denial to a few news channels/newspapers who contacted the Company in this matter".
Nov 2009
16 Nov · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated November 14, 2009, titled "Torrent's New Insulin Facility to produce 26 million vials pa for Novo Nordisk". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
31 Oct · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Q2 operating profit jump 83% at Rs. 118 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Oct · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis as per clause 41 of the Listing Agreement for the quarter and half year ended on September 30, 2009.
Aug 2009
27 Aug · Meeting
Torrent Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the Annual General Meeting held on July 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
29 Jul · Management
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding the auditor's report with respect to the audited financial results for the quarter ended June 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements For more details click here.29 Jul · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's operating profits for the quarter up by 41% at Rs.96 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jul · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company as per clause 41 of the Listing Agreement for the quarter ended on June 30, 2009.6 Jul · Dividend
Torrent Pharmaceuticals Ltd. has informed the Exchange that the dividend on the Equity Shares of the Company for the financial year 2008-09, if approved by the shareholders at the ensuing Annual General Meeting shall be payable on August 03, 2009.3 Jul · Meeting
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Shareholders of the Company will be held on July 29, 2009.
May 2009
27 May · Corporate action
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Share Transfer Books and Registers of Members of the Company will remain close from June 10, 2009 to June 12, 2009 (both days inclusive) for the purpose of Dividend entitlement for the year 2008-09.19 May · Management
Torrent Pharmaceuticals Ltd. has submitted to the Exchange the auditor's report in respect of the Consolidated Financial results for the year ended March 31, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 May · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Net Profit for the year up by 36% at Rs.184 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 May · Dividend
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors at its meeting held on May 15, 2009 has recommended a dividend of Rs.4.00 per equity share having face value of Rs.5/- each.12 May · Management
Torrent Pharmaceuticals Ltd. has informed the Exchange that: "Mihir Thakore, Non Executive Independent Director has tendered his resignation as Director of the Company wef 6-May-09. He has communicated that due to his professional commitments, he was finding it increasingly difficult to devote the required time to affairs of the Board & Audit Committee".5 May · Board meeting
To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2009 and recommendation of dividend for the financial year 2008-09.
Apr 2009
29 Apr · Results
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Company is exercising the option to submit audited financial results for the financial year ended March 31, 2009.
Jan 2009
30 Jan · Management
Torrent Pharmaceuticals Ltd. has submitted to the Exchange the auditor's report in respect of the audited financial results for the quarter ended December 31, 2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Jan · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding the press release, titled "Torrent Pharma Q3 PAT up 36%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on December 31, 2008.
Oct 2008
24 Oct · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding the press release, titled "Torrent Pharma's Q2 net profit jumps 84% at Rs. 48 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Oct · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2008.
Sep 2008
1 Sep · Meeting
Torrent Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of Annual General Meeting of the members of the Company held on July 29, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
31 Jul · Updates
Torrent Pharmaceuticals Ltd. has informed the Exchange with reference to News article titled "Japan Takeda eyes Torrent Pharma" in news paper dated July 31, 2008, that : "Company denies that it or its promoters' intend to sell any stake to Takeda Pharmaceuticals Company, Japan. There is no move on the part of the Company or its promoters to sell stake, in part or in whole, to any player, national or global. The Company had sent its denial to the newpaper when contacted in this matter prior to the publication".29 Jul · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Q1 net Profit up 84% at Rs. 49 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
24 Jun · News Verification
News Verification : The media had reports that Sun Pharmaceuticals may acquire a substantial stake in Torrent Pharmaceuticals Ltd. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Torrent Pharmaceuticals Ltd. has vide its letter inter-alia stated, "Company denies that it or its promoters' intend to sell any stake to Sun Pharmaceuticals Ltd."23 Jun · Change in Registrar & Share Transfer Agent
Torrent Pharmaceuticals Ltd. has informed the Exchange that "The Company has changed the Registrar & Transfer Agent (RTA) from MCS Ltd. to Karvy Computer share Pvt. Ltd. wef June 20, 2008. Further please note both the depositories have shifted connectivity to Karvy Computer share Pvt. Ltd. wef June 20, 2008. Please note the communication details of the New Registrar & Transfer Agent Karvy Computershare Pvt. Ltd. : Karvy Computershare Private Limited , Unit: Torrent Pharmaceuticals Ltd., Plot No. 17 to 24, Vittalrao Nagar, Madhapur, Hyderabad-500081 , Tel No: 040-23420818-24 , Fax No: 040-23420814 , Contact person : K S Reddy , E-mail : einward.ris@karvy.com".
May 2008
28 May · Corporate action
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Share Transfer Books and Register of Members of the Company will remain close from June 23, 2008 to June 25, 2008 (both days inclusive). Dividend entitlement shall get decided based on the same.13 May · Management
Torrent Pharmaceuticals Ltd. has informed the Exchange that : "Prof .S. Ramnarayan, Non Executive Independent Director has tendered his resignation as Director of the Company wef 7-May-08".6 May · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Net Profit up by 44% at Rs. 135 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 May · Dividend
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 06, 2008 has recommended a dividend of Rs.3.50/- per share of Rs. 5/- each
Apr 2008
24 Apr · Board meeting
To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2008 and dividend for 2007-08.7 Apr · Results
Torrent Pharmaceuticals Ltd. has informed the Exchange that: "The Company will publish Audited Financial Results for the year ended March 31, 2008 within 3 months from the end of last quarter i.e. March, 2008. In view of the above, the Unaudited Financial Results for the last quarter of the financial year 2007-08 will not be published".
Jan 2008
24 Jan · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on December 31, 2007.